Belimumab 10 mg/kg vs placebo
Reduction of glucocorticoid dose by at least 50% · people with active systemic lupus erythematosus (but not active nephritis or active central nervous system involvement)
Belimumab 10 mg/kg leads to higher reduction of glucocorticoid dose by at least 50% compared with placebo (high certainty).
1 finding from 1 review
- RR 1.59 [1.17, 2.15]2 studies · 537 participantsHigh